A commonly used treatment for prostate cancer may increase the risk of colorectal cancer.
Older men with prostate cancer who received treatment that reduced androgen had a 30 to 40 percent higher risk of getting colorectal cancer than men who didn’t have the therapy. The longer they received the treatment, the greater their risk.
Androgen deprivation therapy (ADT) is approved for treatment for men with advanced prostate cancer, but its use is controversial in older men with earlier, low-risk cancer although it is widely used in those men.
The link of ADT to colorectal cancer may help lower-risk men make a decision about therapy for their prostate cancer. Read the rest of this entry »